Loading clinical trials...
Loading clinical trials...
Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort. Primary endpoint after 3-6 months: Pat...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Tuebingen
NCT04712851 · Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, and more
NCT06403618 · Cervical Intraepithelial Neoplasia Grade 2
NCT05266898 · Papillomavirus Vaccines, Human Immunodeficiency Virus, and more
NCT05229679 · Human Papilloma Virus, Cervical Intraepithelial Neoplasia, and more
NCT05078528 · Cervical Intraepithelial Neoplasia
Department for Women's Health
Tübingen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions